US20040138740A1 - Tubular medical endoprostheses - Google Patents
Tubular medical endoprostheses Download PDFInfo
- Publication number
- US20040138740A1 US20040138740A1 US10/751,749 US75174904A US2004138740A1 US 20040138740 A1 US20040138740 A1 US 20040138740A1 US 75174904 A US75174904 A US 75174904A US 2004138740 A1 US2004138740 A1 US 2004138740A1
- Authority
- US
- United States
- Prior art keywords
- metal
- core
- filament
- outer member
- stent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/082—Inorganic materials
- A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B1/00—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B1/22—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting goods of particular configuration
- D04B1/225—Elongated tubular articles of small diameter, e.g. coverings or reinforcements for cables or hoses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09166—Guide wires having radio-opaque features
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2101/00—Inorganic fibres
- D10B2101/20—Metallic fibres
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2401/00—Physical properties
- D10B2401/04—Heat-responsive characteristics
- D10B2401/046—Shape recovering or form memory
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/06—Vascular grafts; stents
Definitions
- This invention relates to tubular endoprostheses to be used inside the body.
- Tubular endoprostheses such as medical stents are placed within the body to perform a function such as maintaining a body lumen open, for example, a passageway occluded by a tumor or a blood vessel restricted by plaque.
- Tubular endoprostheses in the form of grafts are used to substitute for or reinforce a lumen, such as the aorta or other blood vessels which have been weakened, e.g., by an aneurysm.
- these endoprostheses are delivered inside the body by a catheter that supports the device in a compacted or otherwise reduced-size form as it is transported to the desired site.
- the size is particularly small when a percutaneous insertion technique is employed.
- the endoprosthesis is expanded so that it engages the walls of the lumen.
- the expansion mechanism may involve forcing the endoprosthesis to expand radially outwardly, for example, by inflation of a balloon carried by the catheter, to plastically deform and fix the device at a predetermined expanded position in contact with the lumen wall.
- the expanding means, the balloon can then be deflated and the catheter removed.
- the endoprosthesis is formed of a highly elastic material that can be reversibly compacted and expanded. During introduction into the body, the endoprosthesis is restrained in the compacted condition and upon reaching the desired site for implantation, the restraint is removed, enabling the device to self-expand by its own internal elastic restoring force.
- X-ray fluoroscopy is used to view an endoprosthesis within the body cavity to monitor placement and operation.
- the device may also be viewed by X-ray film after placement for medical follow-up evaluation.
- radiopacity has limited the construction of devices to certain materials which in turn has limited the features attainable for particular applications and the available insertion techniques.
- metal such as in the form of wire or filament or the like is used for constructing tubular medical endoprosthesis such as stents.
- Desirable attributes of these wires vary with the stent application, but include properties such as stiffness, tensile strength, elasticity, radiopacity, weldability, flexural life, conductivity, etc. These properties are hard to find in conventional wires.
- desired properties are achieved by creating a multiple metal coaxial construction. For example, it may be very desirable to have high radiopacity along with elasticity and strength. This is accomplished by combining a radiopaque metal with an elastic metal.
- the dense radiopaque material e.g., tantalum
- the elastic material e.g., titanium or nickel-titanium alloy
- an aspect of the invention is a metal stent device with at least a portion to be used within the body having properties that can be tailored to a particular application.
- the portion within the body is formed of preferably two or more dissimilar metals joined together to form a unitary member.
- each metal contributes a desirable property to the device which is not substantially impaired by the presence of the other metal.
- one metal provides enhanced radiopacity.
- the stent is comprised of a metal outer member having a predetermined density and an exposed outer surface and a core including a metal having a density greater than the outer member to enhance radiopacity. The core is secured within and substantially enclosed by the outer member.
- the stent is configured such that the mechanical properties, for example, the elastic properties, of the metal forming the outer member are affected by the core to a desired degree so that the stent has a desired overall performance suitable for its intended use.
- the mechanical properties of the outer member dominate the properties of the stent yet the radiopacity of the member is substantially enhanced by the denser core.
- the invention also allows increased radiopacity of the stent without adversely affecting and in some cases improving other important properties such as the biocompatibility, small size or other performance characteristics.
- metal as used herein includes electropositive chemical elements characterized by ductility, malleability, luster, and conductivity of heat and electricity, which can replace the hydrogen of an acid and forms bases with the hydroxyl radical and including mixtures including these elements and alloys. Many examples are given below.
- An aspect of the invention features a tubular prosthesis device for use within the body.
- Forming the tubular endoprosthesis is a metal filament material comprised of a metal outer member of extended length having an exposed outer surface and a core within the extended outer member formed of a different metal than the outer member.
- the core is secured within and substantially enclosed by the outer member.
- the device is capable of reduction to a small size for introduction into the body lumen and expandable to a sufficiently large size to engage the wall of the body lumen.
- the outer member and core are such that the endoprosthesis is elastic and capable of radial reduction in size without plastic deformation to the small size for introduction to the body and self-expandable by an internal elastic self-restoring force to the large size for engaging the wall of the lumen.
- the outer member and core are such that the endoprosthesis is plastically deformable; it is formed of small size for introduction into the body and expandable by plastic deformation to the large size for engaging the wall of the lumen.
- the device is formed into the tubular shape by knitting of the wire or filament into loosely interlocked loops of the filament.
- the metal of the core has a density greater than the metal of the outer member of the device.
- the cross sectional dimension of the filament is about 0.015 inch or less.
- the cross-sectional dimension of the filament is about 0.006 to about 0.0045 inch and the core has a cross-sectional dimension of about 0.0014 to about 0.00195 inch.
- the core has a density of about 9.9 g/cc or greater.
- the core is selected form the group consisting of tungsten, tantalum, rhenium, iridium, silver, gold, bismuth and platinum.
- the outer member is selected from superelastic alloys and precursors of superelastic alloys and stainless steel.
- the outer member is nitinol.
- the core is tantalum.
- Another, particular aspect of the invention features a self-expanding tubular prosthesis device for use within the body formed of loosely interlocked knitted loops of a metal filament material.
- the filament is formed of an elastic metal capable of deflection without plastic deformation to produce a self-restoring force.
- the filament material is formed of an elastic metal outer member of extended length having high elasticity and an exposed outer surface, and a core of a different metal than the outer member, which core is secured within and substantially enclosed by the outer member.
- the device is capable of reduction to a small size for introduction into the body lumen and expandable by the internal restoring force to a sufficiently large size to engage the wall of the body lumen.
- the core is about 25% or more of the cross-sectional dimension.
- the core is between about 1 and 40%, e.g. about 28% or less, preferably 33% of the cross-sectional dimension.
- the core has a modulus of elasticity of about 500 GPa or less, such as about 200 GPa or less.
- the invention features a medical stent device capable of placement or manipulation in the body by means external of the body under guidance of a fluoroscope.
- the device is at least in part an elongated filament-form metal member adapted to be subjected to elastic deformation to enable the device to be forced into a characteristic deformed configuration during a stage of use and to elastically self-recover from the deformation when deformation forces are relieved.
- the filament-form metal member includes a core of a first metal of a first selected thickness and an intimately surrounding sheath of a second selected metal of a second thickness.
- the first metal is a high density metal that demonstrates characteristic relatively high radiopacity and the second metal is a lower density metal having substantially more elasticity than the first metal.
- the combined effect of the selected thicknesses of the first and second metals in the filament-form member serves to enhance the radio-opacity of the filament-form member to provide improved fluoroscopic or x-ray visualization of the filament-form member in the body while imparting sufficient elasticity to enable the filament-form member to elastically self-recover from its characteristic deformed configuration.
- the invention features a tubular endoprosthesis formed of a metal member.
- the metal member has a cross-sectional thickness of about 0.015 inch or less, more preferably 0.0075 inch or less, and is composed of at least two different metals, including an exposed outer metal having selected mechanical properties and an inner metal encompassed within the outer metal, the inner metal having a relatively high density compared to the outer metal for enhancing the radiopacity of the endoprosthesis.
- the filament is formed by draw-forming techniques employing a large starting member which has a core of metal of different properties than a surrounding metal shell.
- the invention also includes methods for the use and construction of the endoprostheses described.
- FIG. 1 is a perspective view of a stent according to the invention, while FIG. 1 a is an enlarged view of adjacent loops of a filament knitted to form the stent;
- FIG. 2 is a highly enlarged schematic cross-sectional view of the stent filament in FIG. 1 a across the lines 22 ; while FIG. 2 a is a similarly enlarged longitudinal cross-sectional view of a portion of the filament;
- FIG. 3 is a schematic longitudinal cross-sectional view of a stent filament according to FIG. 2 in a bent configuration
- FIGS. 4 to 4 b illustrate placement of a self-expanding stent according to the invention
- FIGS. 5 to 5 b illustrate placement of a plastically deformable stent according to the invention
- FIG. 6 is a graph of load as a function of displacement for several stent wires according to the invention.
- an endoprosthesis stent 10 is adapted for use in the biliary tree and formed of an elastic filament 11 knitted into a mesh cylinder 12 that extends to ends 14 , 14 ′ coaxially along axis 13 over a working length L, about 4-6 cm and has a maximum expanded diameter, D, of about 9-10 mm.
- the knitting forms a series of loosely interlocked knitted loops (e.g., as indicated by adjacent loops 16 , 16 ′, FIG. 1 a ) which may slide with respect to each other when the stent is radially compacted, for example, when delivered into the biliary duct on a catheter as further discussed below.
- the filament 11 is a wire-form member that includes a longitudinal outer member 4 concentrically disposed about a central core 8 which extends along an axis 6 .
- the longitudinal member 4 having an outer diameter, d o about 0.0052 inch, is formed of a metal, such as nitinol, that exhibits desirable properties, such as high elasticity and biocompatibility of its exposed outer surface 7 .
- the surface 7 may include a non-metal coating of, e.g., fluorocarbons, silicones, hydrophilic and lubricous biocompatible materials.
- the core 8 is bonded to and substantially enclosed by the outer member 4 such that the core does not have any substantial exposed surface and therefore does not contact body tissue when positioned within the body during use.
- the core 8 is a continuous solid member in intimate contact with and bonded to the interior portions of the outer member 4 without the formation of substantial voids in the interface 10 between the core and outer member.
- the elastic properties of the filament 11 are dominated by the elastic properties of the longitudinal member 4 .
- the core material 8 enhances the radiopacity of the filament 11 but preferably does not substantially affect the mechanical performance of the filament.
- a stent can be formed of a composite filament exhibiting substantially the elasticity properties of, for example, a solid elastic (used in linear range) or superelastic nitinol filament, (to form, for example, a self-expanding stent), despite the presence of a dense, e.g. tantalum, core, and that the stent formed of the composite filament is more radiopaque than a stent formed of a solid nitinol filament.
- the filament 11 is shown in a bent position, as it may be, for example when in use in a knitted stent device.
- the inner and outer portions (I) and (O), respectively, experience a wide range of compression and tension, as the filament is bent such as during knitting of the stent and during placement of the stent and in use.
- An advantage of the filament is that by positioning the radiopaque core material 8 near the axis 6 , the range of tension and compression imposed on the core is relatively small and a wide latitude of stiff, dense, strong, and/or substantially radiopaque materials can be used which otherwise might not be suitable for their response to bending or other properties.
- the characteristics of the filament and thus the selection of the outer member and core metals is based on the stent application.
- Particularly preferred uses of stents of the invention are for the biliary tree (e.g. 8 -12 mm diameter, 2-8 cm length) such as the hepatic and pancreatic duct (e.g. 4-12 mm diameter), the urinary tract including the prostate and urethra (e.g. 14-15 mm, diameter; 3-4 cm, length) and the ureter (e.g. 3-4 mm diameter), and the vasculature including the hepatic vasculature e.g. for the treatment of portal hypertension (e.g.
- a filament with a larger outer diameter, d o may be used for larger stents.
- a filament outer diameter, d o in the range of 0.008 inch may be used in the case of an aortic stent.
- the dimension of the core (d c ) is less than about 50% (but typically greater than about 1%) of the outer diameter of the filament, more preferably between about 40% and 25%, for example about 33%.
- Embodiments of the stent having enhanced radiopacity are especially useful in applications where the stent must be sized small with, for example, a stent wire outer diameter (d o ) of less than about 0.015 inch, e.g., even less than 0.0075 inch and for which less dense metals are required for advantageous elastic properties.
- the filament is formed of nitinol with an outer diameter, d o , of about 0.006 inch and a core of tantalum with diameter, d c , at about 0.002 inch.
- stent 10 is a self-expanding stent that may be introduced to a body lumen 20 such as the biliary tree.
- the stent 10 is positioned on a catheter 24 which includes a sleeve 26 to maintain the stent 10 in a relatively compact form (FIG. 4). This is typically achieved by rolling the stent upon itself and a pair of tiny mandrels that nip a portion of the wall of the stent and are rotated bodily together until the full circumference of the stent is taken up in the resulting rolled up form.
- the stent may be positioned coaxially over the catheter.
- the catheter is positioned within the lumen at the region corresponding to a tumor 22 and the sleeve 26 is removed from about the stent 10 , for example, by withdrawing axially in the direction of arrow 28 , thus causing the stent 10 to radially expand by release of its internal restoring force (FIG. 4 a ).
- the internal restoring force is sufficient to dilate the lumen 20 by pushing the tumor growth 22 radially outward (or in some cases compressing the occlusion against the lumen wall), thus opening a passage that allows unobstructed flow through the lumen and allowing removal of the catheter 24 (FIG. 4 b ).
- the stent may be compressed in a tube having a distal axial opening and be pushed from the end of the tube, whereby it self-expands.
- the stent may also be a plastically deformable tube-like knitted structure 50 .
- the individual filament meshes interlock loosely in a looped pattern and during radial expansion of the knitted structure loops forming the individual meshes are deformed beyond the elastic limits of the filament, resulting in plastic deformation of the filament.
- Stent 50 is placed over a balloon 51 carried near the distal end of a catheter 52 .
- the catheter 52 is directed through a lumen 54 , e.g., a blood vessel until the portion carrying the balloon and stent reaches the region of the occlusion 53 (FIG. 5).
- the stent 50 is then radially expanded beyond its elastic limit by the admission of pressure to the balloon 51 and compressed against the vessel wall with the result that occlusion 53 is compressed, and the vessel wall surrounding it undergoes a radial expansion (FIG. 5 a ).
- the pressure is then released from the balloon and the catheter is withdrawn from the vessel (FIG. 5 b ).
- the stent in the balloon expandable embodiment is preferably formed with a dense radiopaque core formed of tantalum and an outer member formed of plastically deformable stainless steel. While the stent filament is plastically deformable, the filament may be selected to have elasticity sufficient to meet the needs of the particular vessel.
- self-expanding stents such as discussed above with respect to FIG. 4 et seq. can be used with a balloon delivery system to aid dilatation of a body lumen.
- the metals used in the filament and their configuration are selected to exhibit various desirable characteristics.
- the relative dimension of the core and outer member and the particular materials used for these elements may be selected based on the desired over-all mechanical properties of the stent and the degree to which x-ray visibility is to be enhanced, since the core affects the mechanical properties of the filament compared to a solid filament formed of the outer material, and the radiopacity is a function of the sum of the mass between an x-ray beam source and detector.
- a knitted stent with overlapping portions may require less radiopaque material to provide sufficient visibility.
- the location of use in the body may affect the amount of dense material needed for sufficient visibility.
- the visibility of a device can be tested by known techniques such as ASTM Designation F640-79 “Standard Test Method for Radiopacity of Plastics for Medical Use”. In this test, the background densities which may be encountered clinically are mimicked by an aluminum plate positioned over the stent having various thicknesses.
- the properties of the outer member metal and core which may be considered include density, modulus of elasticity (in annealed and hardened states), biocompatability (primarily a factor for the material of the outer longitudinal member), flexural stiffness, durability, tensile and compression strength, and the required radiopacity and resolution.
- the inner and outer metals may be the same metal or metals of the same elemental composition that are different metals because of e.g., different crystal structure or other properties.
- the outer member is formed of a continuous solid mass of a highly elastic biocompatible metal such as a superelastic or pseudo-elastic metal alloy, for example, a nitinol (e.g., 55% nickel, 45% titanium).
- a highly elastic biocompatible metal such as a superelastic or pseudo-elastic metal alloy, for example, a nitinol (e.g., 55% nickel, 45% titanium).
- superelastic materials include, e.g., Silver-Cadmium (Ag—Cd), Gold-Cadmium (Au—Cd), Gold-Copper-Zinc (Au—Cu—Zn), Copper-Aluminum-Nickel (Cu—Al—Ni), Copper-Gold-Zinc (Cu—Au—Zn), Copper-Zinc (Cu—Zn), Copper-Zinc-aluminum (Cu—Zn—Al), Copper-Zinc-Tin (Cu—Zn—Sn), Copper-Zinc-Xenon (Cu—Zn—Xe), Iron Beryllium (Fe 3 Be), Iron Platinum (Fe 3 Pt), Indium-Thallium (In—Tl), iron-manganese (Fe—Mn) Nickel-Titanium-Vanadium (Ni—Ti—V), Iron-Nickel-Titanium-Cobalt (Fe—Ni—Ti—Co) and Copper-Tin (
- nitinol or other highly elastic metal is employed as the outer member, in an arrangement in which it is never stressed beyond the straight line portion of its stress strain curve.
- metals suitable for the outer member include stainless steel or the precursor of superelastic alloys.
- Precursors of superelastic alloys are those alloys which have the same chemical constituents as superelastic alloys, but have not been processed to impart the superelastic property under the conditions of use.
- the core material is preferably a continuous solid mass, but may also be in a powder-form.
- the core includes a metal that is relatively dense to enhance radiopacity.
- the core metal has a density of about 9.9 g/cc or greater.
- Other preferred materials and their density include tungsten (19.3 g/cc), rhenium (21.2 g/cc), bismuth (9.9 g/cc), silver (16.49 g/cc), gold (19.3 g/cc), platinum (21.45 g/cc), and iridium (22.4 g/cc).
- the core is somewhat stiffer than the outer member.
- the core metal has a low modulus of elasticity, e.g., preferably below about 550 GPa, e.g., such as tantalum (186 GPa).
- a smaller difference between the modulus of elasticity between the outer material and core results in a smaller variation of the modulus from that of the outer material in the filament of the invention.
- a smaller core may be used so as to produce a filament in which the elastic properties are dominated by the outer material.
- the outer member and core may be in many cross-sectional geometric configurations, such as circular, square, triangular, hexagonal, octagonal, trapezoidal and the geometrical configuration of the core may differ from that of the longitudinal member.
- the outer member of a filament may be rectangular in cross-section with a rectangular core or triangular or hexagonal in cross-section with a circular core.
- a stent filament may also take on the form of tubing with a lumen within the core extending along the axis.
- a stent filament may also include successive layers of less dense outer material and more dense core material to form a multi-composite system of three layers or more from exterior to center.
- the core may extend intermittently along the axis in a desired pattern.
- the filament may be a draw-form member formed, for example, by drilling out the center of a relatively large rod of the outer member material to form a bore, positioning a rod of core material in the bore, sealing the ends of the bore, e.g., by crimping, and drawing the form through a series of dies of decreasing diameter until the desired outer diameter is achieved.
- the component may be heat treated to anneal, harden or impart superelastic properties. Other methods of formation are also possible, e.g., by coating the core with the desired outer material such as by electro- or electroless plating.
- the materials used in the outer member and core are also selected based on their workability for forming the filament, including factors such as machinability, for forming the longitudinal member into a tubular piece and the core member into a rod shaped piece, stability in gaseous environments at annealing temperatures, properties related to drawing, welding, forging; swaging, the ability to accept coatings such as adhesives, polymers, lubricants and practical aspects such as cost and availability.
- the stents of the invention are preferably constructed by knitting a filament, most preferably on a circular knitting machine. Knitted metal stents are discussed, for example, in Strecker, U.S. Pat. No. 4,922,905. It will be appreciated that the stent may be formed from a composite metal filament by other means such as weaving, crocheting, or forming the filament into a spiral-spring form element. It will further be appreciated that the composite filament may be incorporated within a stent formed from conventional metal or non-metal materials (e.g. dacron in the case of an aortic graft) to contribute desirable properties such as strength and/or radiopacity. The stent may also be in the form of a metal member configured as other than a filament-form, e.g., a composite sheet form member in the form of a cuff or tube.
- An elastic, radiopaque filament for use in a stent may be formed as follows.
- a 500 foot length of filament (0.0052 inch in diameter) having an outer member formed of a precursor of a nitinol (55% Ni/45% Ti) superelastic alloy and a core material of tantalum (0.00175 inch in diameter) is formed by drilling a 0.25 inch diameter bore in a 0.75 inch rod of the outer member material and providing in the drilled lumen a tantalum member of substantially matched outer diameter.
- the rod is mechanically forged in a standard hot forging and rolling apparatus, then hammered such that no substantial voids between the core and outer longitudinal member are present.
- the outer member of the filament is the precursor of a superelastic alloy, i.e., it has not been heat treated to impart the superelastic property under the anticipated conditions of use.
- the stress at which constant displacement occurs decreases with increasing annealing, as would be expected with a superelastic material.
- the mechanical properties of the filament therefore, are dominated by the nitinol alloy, despite the presence of the tantalum core.
- the modulus of elasticity of the filaments of the invention was varied less than 30% compared to the solid Ni—Ti filament.
- the plateau stress of the filaments of the invention using a superelastic outer member was varied less than about 10% compared to a solid Ni—Ti superelastic filament.
- the composite filament formed as described exhibits about 30% or more enhanced x-ray visibility over a filament of the same thickness formed of solid nitinol.
- filaments as described dominated by the mechanical properties of an outer member, such as nitinol, and exhibiting generally satisfactory radiopacity have outer diameter (d o ) of about 0.008 to 0.0045 inch with a core, for example of tantalum, with diameter (d c ) of about 0.0014 to 0.00195 inch.
Abstract
Description
- This invention relates to tubular endoprostheses to be used inside the body.
- Tubular endoprostheses such as medical stents are placed within the body to perform a function such as maintaining a body lumen open, for example, a passageway occluded by a tumor or a blood vessel restricted by plaque. Tubular endoprostheses in the form of grafts are used to substitute for or reinforce a lumen, such as the aorta or other blood vessels which have been weakened, e.g., by an aneurysm.
- Typically, these endoprostheses are delivered inside the body by a catheter that supports the device in a compacted or otherwise reduced-size form as it is transported to the desired site. The size is particularly small when a percutaneous insertion technique is employed. Upon reaching the site, the endoprosthesis is expanded so that it engages the walls of the lumen.
- The expansion mechanism may involve forcing the endoprosthesis to expand radially outwardly, for example, by inflation of a balloon carried by the catheter, to plastically deform and fix the device at a predetermined expanded position in contact with the lumen wall. The expanding means, the balloon, can then be deflated and the catheter removed.
- In another technique, the endoprosthesis is formed of a highly elastic material that can be reversibly compacted and expanded. During introduction into the body, the endoprosthesis is restrained in the compacted condition and upon reaching the desired site for implantation, the restraint is removed, enabling the device to self-expand by its own internal elastic restoring force.
- In many cases, X-ray fluoroscopy is used to view an endoprosthesis within the body cavity to monitor placement and operation. The device may also be viewed by X-ray film after placement for medical follow-up evaluation. To date, the requirement for radiopacity has limited the construction of devices to certain materials which in turn has limited the features attainable for particular applications and the available insertion techniques.
- In the invention, metal such as in the form of wire or filament or the like is used for constructing tubular medical endoprosthesis such as stents. Desirable attributes of these wires vary with the stent application, but include properties such as stiffness, tensile strength, elasticity, radiopacity, weldability, flexural life, conductivity, etc. These properties are hard to find in conventional wires. According to the invention, desired properties are achieved by creating a multiple metal coaxial construction. For example, it may be very desirable to have high radiopacity along with elasticity and strength. This is accomplished by combining a radiopaque metal with an elastic metal. Although it is possible to put either metal on the inside or outside, it is preferable to put the dense radiopaque material (e.g., tantalum) on the inside (core) since dense materials are generally less elastic and the elastic material (e.g., titanium or nickel-titanium alloy) on the outside (clad). The clad or “skin” of the wire will undergo more deformation in bending than the core, so the elastic component is best positioned at the skin.
- Thus, an aspect of the invention is a metal stent device with at least a portion to be used within the body having properties that can be tailored to a particular application. The portion within the body is formed of preferably two or more dissimilar metals joined together to form a unitary member. Typically, each metal contributes a desirable property to the device which is not substantially impaired by the presence of the other metal. In particularly preferred devices, one metal provides enhanced radiopacity. In these embodiments, the stent is comprised of a metal outer member having a predetermined density and an exposed outer surface and a core including a metal having a density greater than the outer member to enhance radiopacity. The core is secured within and substantially enclosed by the outer member. Preferably, the stent is configured such that the mechanical properties, for example, the elastic properties, of the metal forming the outer member are affected by the core to a desired degree so that the stent has a desired overall performance suitable for its intended use. Preferably, the mechanical properties of the outer member dominate the properties of the stent yet the radiopacity of the member is substantially enhanced by the denser core. The invention also allows increased radiopacity of the stent without adversely affecting and in some cases improving other important properties such as the biocompatibility, small size or other performance characteristics. These performance advantages can be realized by proper selection of the material of the outer member and core, their relative size, and geometrical configuration. The particular performance characteristics to be achieved are dictated by the stent application.
- The term “metal” as used herein includes electropositive chemical elements characterized by ductility, malleability, luster, and conductivity of heat and electricity, which can replace the hydrogen of an acid and forms bases with the hydroxyl radical and including mixtures including these elements and alloys. Many examples are given below.
- An aspect of the invention features a tubular prosthesis device for use within the body. Forming the tubular endoprosthesis is a metal filament material comprised of a metal outer member of extended length having an exposed outer surface and a core within the extended outer member formed of a different metal than the outer member. The core is secured within and substantially enclosed by the outer member. The device is capable of reduction to a small size for introduction into the body lumen and expandable to a sufficiently large size to engage the wall of the body lumen.
- In some preferred embodiments, the outer member and core are such that the endoprosthesis is elastic and capable of radial reduction in size without plastic deformation to the small size for introduction to the body and self-expandable by an internal elastic self-restoring force to the large size for engaging the wall of the lumen.
- In other embodiments, the outer member and core are such that the endoprosthesis is plastically deformable; it is formed of small size for introduction into the body and expandable by plastic deformation to the large size for engaging the wall of the lumen.
- Various embodiments of the invention may also include one or more of the following features. The device is formed into the tubular shape by knitting of the wire or filament into loosely interlocked loops of the filament. The metal of the core has a density greater than the metal of the outer member of the device. The cross sectional dimension of the filament is about 0.015 inch or less. The cross-sectional dimension of the filament is about 0.006 to about 0.0045 inch and the core has a cross-sectional dimension of about 0.0014 to about 0.00195 inch. The core has a density of about 9.9 g/cc or greater. The core is selected form the group consisting of tungsten, tantalum, rhenium, iridium, silver, gold, bismuth and platinum. The outer member is selected from superelastic alloys and precursors of superelastic alloys and stainless steel. The outer member is nitinol. The core is tantalum.
- Another, particular aspect of the invention features a self-expanding tubular prosthesis device for use within the body formed of loosely interlocked knitted loops of a metal filament material. The filament is formed of an elastic metal capable of deflection without plastic deformation to produce a self-restoring force. The filament material is formed of an elastic metal outer member of extended length having high elasticity and an exposed outer surface, and a core of a different metal than the outer member, which core is secured within and substantially enclosed by the outer member. The device is capable of reduction to a small size for introduction into the body lumen and expandable by the internal restoring force to a sufficiently large size to engage the wall of the body lumen.
- Various embodiments of this aspect as well as other aspects may include the features already mentioned as well as one or more of the following features. The core is about 25% or more of the cross-sectional dimension. The core is between about 1 and 40%, e.g. about 28% or less, preferably 33% of the cross-sectional dimension. The core has a modulus of elasticity of about 500 GPa or less, such as about 200 GPa or less.
- In another aspect the invention features a medical stent device capable of placement or manipulation in the body by means external of the body under guidance of a fluoroscope. The device is at least in part an elongated filament-form metal member adapted to be subjected to elastic deformation to enable the device to be forced into a characteristic deformed configuration during a stage of use and to elastically self-recover from the deformation when deformation forces are relieved. The filament-form metal member includes a core of a first metal of a first selected thickness and an intimately surrounding sheath of a second selected metal of a second thickness. The first metal is a high density metal that demonstrates characteristic relatively high radiopacity and the second metal is a lower density metal having substantially more elasticity than the first metal. The combined effect of the selected thicknesses of the first and second metals in the filament-form member serves to enhance the radio-opacity of the filament-form member to provide improved fluoroscopic or x-ray visualization of the filament-form member in the body while imparting sufficient elasticity to enable the filament-form member to elastically self-recover from its characteristic deformed configuration.
- In another aspect, the invention features a tubular endoprosthesis formed of a metal member. The metal member has a cross-sectional thickness of about 0.015 inch or less, more preferably 0.0075 inch or less, and is composed of at least two different metals, including an exposed outer metal having selected mechanical properties and an inner metal encompassed within the outer metal, the inner metal having a relatively high density compared to the outer metal for enhancing the radiopacity of the endoprosthesis.
- In various embodiments of any of the aspects of the invention the filament is formed by draw-forming techniques employing a large starting member which has a core of metal of different properties than a surrounding metal shell.
- The invention also includes methods for the use and construction of the endoprostheses described.
- Still other aspects of the invention will be understood from the following description and from the claims.
- We first briefly describe the drawings.
- FIG. 1 is a perspective view of a stent according to the invention, while FIG. 1a is an enlarged view of adjacent loops of a filament knitted to form the stent;
- FIG. 2 is a highly enlarged schematic cross-sectional view of the stent filament in FIG. 1a across the
lines 22; while FIG. 2a is a similarly enlarged longitudinal cross-sectional view of a portion of the filament; - FIG. 3 is a schematic longitudinal cross-sectional view of a stent filament according to FIG. 2 in a bent configuration;
- FIGS.4 to 4 b illustrate placement of a self-expanding stent according to the invention;
- FIGS.5 to 5 b illustrate placement of a plastically deformable stent according to the invention;
- FIG. 6 is a graph of load as a function of displacement for several stent wires according to the invention.
- Referring to FIGS. 1 and 1a, an
endoprosthesis stent 10 according to a preferred embodiment is adapted for use in the biliary tree and formed of anelastic filament 11 knitted into amesh cylinder 12 that extends to ends 14, 14′ coaxially alongaxis 13 over a working length L, about 4-6 cm and has a maximum expanded diameter, D, of about 9-10 mm. The knitting forms a series of loosely interlocked knitted loops (e.g., as indicated byadjacent loops - Referring to FIGS. 2 and 2a, the
filament 11 is a wire-form member that includes a longitudinalouter member 4 concentrically disposed about acentral core 8 which extends along anaxis 6. Thelongitudinal member 4, having an outer diameter, do about 0.0052 inch, is formed of a metal, such as nitinol, that exhibits desirable properties, such as high elasticity and biocompatibility of its exposedouter surface 7. (Thesurface 7 may include a non-metal coating of, e.g., fluorocarbons, silicones, hydrophilic and lubricous biocompatible materials.) Thecore 8 having a diameter, dc, about 0.00175 inch, includes a metal, such as tantalum, with a density greater than thelongitudinal member 4 to enhance the radiopacity of the filament and thus the stent from which it is formed. Thecore 8 is bonded to and substantially enclosed by theouter member 4 such that the core does not have any substantial exposed surface and therefore does not contact body tissue when positioned within the body during use. As illustrated, preferably thecore 8 is a continuous solid member in intimate contact with and bonded to the interior portions of theouter member 4 without the formation of substantial voids in theinterface 10 between the core and outer member. Preferably, the elastic properties of thefilament 11 are dominated by the elastic properties of thelongitudinal member 4. Thecore material 8 enhances the radiopacity of thefilament 11 but preferably does not substantially affect the mechanical performance of the filament. One aspect of the present invention is that it has been discovered that a stent can be formed of a composite filament exhibiting substantially the elasticity properties of, for example, a solid elastic (used in linear range) or superelastic nitinol filament, (to form, for example, a self-expanding stent), despite the presence of a dense, e.g. tantalum, core, and that the stent formed of the composite filament is more radiopaque than a stent formed of a solid nitinol filament. - Referring to FIG. 3, the
filament 11 is shown in a bent position, as it may be, for example when in use in a knitted stent device. The inner and outer portions (I) and (O), respectively, experience a wide range of compression and tension, as the filament is bent such as during knitting of the stent and during placement of the stent and in use. An advantage of the filament is that by positioning theradiopaque core material 8 near theaxis 6, the range of tension and compression imposed on the core is relatively small and a wide latitude of stiff, dense, strong, and/or substantially radiopaque materials can be used which otherwise might not be suitable for their response to bending or other properties. - Parameter Selection
- Generally, the characteristics of the filament and thus the selection of the outer member and core metals, is based on the stent application. Particularly preferred uses of stents of the invention are for the biliary tree (e.g. 8 -12 mm diameter, 2-8 cm length) such as the hepatic and pancreatic duct (e.g. 4-12 mm diameter), the urinary tract including the prostate and urethra (e.g. 14-15 mm, diameter; 3-4 cm, length) and the ureter (e.g. 3-4 mm diameter), and the vasculature including the hepatic vasculature e.g. for the treatment of portal hypertension (e.g. 4-10 mm diameter; 5-6 cm, length), the neurovasculature (e.g. 1 mm, diameter) and the aorta (e.g. 20 mm, diameter) for example, for treatment of aneurysms or lesions. A filament with a larger outer diameter, do, may be used for larger stents. For example, a filament outer diameter, do, in the range of 0.008 inch may be used in the case of an aortic stent.
- Typically, the dimension of the core (dc) is less than about 50% (but typically greater than about 1%) of the outer diameter of the filament, more preferably between about 40% and 25%, for example about 33%. Embodiments of the stent having enhanced radiopacity are especially useful in applications where the stent must be sized small with, for example, a stent wire outer diameter (do) of less than about 0.015 inch, e.g., even less than 0.0075 inch and for which less dense metals are required for advantageous elastic properties. For example, in another embodiment the filament is formed of nitinol with an outer diameter, do, of about 0.006 inch and a core of tantalum with diameter, dc, at about 0.002 inch.
- Referring to FIGS.4 to 4 b, in embodiments such as that discussed with respect to FIGS. 1 and 1a,
stent 10 is a self-expanding stent that may be introduced to abody lumen 20 such as the biliary tree. Thestent 10 is positioned on acatheter 24 which includes asleeve 26 to maintain thestent 10 in a relatively compact form (FIG. 4). This is typically achieved by rolling the stent upon itself and a pair of tiny mandrels that nip a portion of the wall of the stent and are rotated bodily together until the full circumference of the stent is taken up in the resulting rolled up form. In other cases, the stent may be positioned coaxially over the catheter. The catheter is positioned within the lumen at the region corresponding to atumor 22 and thesleeve 26 is removed from about thestent 10, for example, by withdrawing axially in the direction ofarrow 28, thus causing thestent 10 to radially expand by release of its internal restoring force (FIG. 4a). The internal restoring force is sufficient to dilate thelumen 20 by pushing thetumor growth 22 radially outward (or in some cases compressing the occlusion against the lumen wall), thus opening a passage that allows unobstructed flow through the lumen and allowing removal of the catheter 24 (FIG. 4b). - In another embodiment, the stent may be compressed in a tube having a distal axial opening and be pushed from the end of the tube, whereby it self-expands.
- Referring now to FIGS.5 to 5 b, the stent may also be a plastically deformable tube-like
knitted structure 50. The individual filament meshes interlock loosely in a looped pattern and during radial expansion of the knitted structure loops forming the individual meshes are deformed beyond the elastic limits of the filament, resulting in plastic deformation of the filament.Stent 50 is placed over aballoon 51 carried near the distal end of acatheter 52. Thecatheter 52 is directed through alumen 54, e.g., a blood vessel until the portion carrying the balloon and stent reaches the region of the occlusion 53 (FIG. 5). Thestent 50 is then radially expanded beyond its elastic limit by the admission of pressure to theballoon 51 and compressed against the vessel wall with the result thatocclusion 53 is compressed, and the vessel wall surrounding it undergoes a radial expansion (FIG. 5a). The pressure is then released from the balloon and the catheter is withdrawn from the vessel (FIG. 5b). - The stent in the balloon expandable embodiment is preferably formed with a dense radiopaque core formed of tantalum and an outer member formed of plastically deformable stainless steel. While the stent filament is plastically deformable, the filament may be selected to have elasticity sufficient to meet the needs of the particular vessel. In addition, self-expanding stents, such as discussed above with respect to FIG. 4 et seq. can be used with a balloon delivery system to aid dilatation of a body lumen.
- In various embodiments, the metals used in the filament and their configuration are selected to exhibit various desirable characteristics. For example, the relative dimension of the core and outer member and the particular materials used for these elements may be selected based on the desired over-all mechanical properties of the stent and the degree to which x-ray visibility is to be enhanced, since the core affects the mechanical properties of the filament compared to a solid filament formed of the outer material, and the radiopacity is a function of the sum of the mass between an x-ray beam source and detector. A knitted stent with overlapping portions, may require less radiopaque material to provide sufficient visibility. Similarly, the location of use in the body may affect the amount of dense material needed for sufficient visibility. The visibility of a device can be tested by known techniques such as ASTM Designation F640-79 “Standard Test Method for Radiopacity of Plastics for Medical Use”. In this test, the background densities which may be encountered clinically are mimicked by an aluminum plate positioned over the stent having various thicknesses.
- The properties of the outer member metal and core which may be considered include density, modulus of elasticity (in annealed and hardened states), biocompatability (primarily a factor for the material of the outer longitudinal member), flexural stiffness, durability, tensile and compression strength, and the required radiopacity and resolution. In some cases, if desirable, the inner and outer metals may be the same metal or metals of the same elemental composition that are different metals because of e.g., different crystal structure or other properties.
- In other embodiments of elastic filament members, the outer member is formed of a continuous solid mass of a highly elastic biocompatible metal such as a superelastic or pseudo-elastic metal alloy, for example, a nitinol (e.g., 55% nickel, 45% titanium). Other examples of superelastic materials include, e.g., Silver-Cadmium (Ag—Cd), Gold-Cadmium (Au—Cd), Gold-Copper-Zinc (Au—Cu—Zn), Copper-Aluminum-Nickel (Cu—Al—Ni), Copper-Gold-Zinc (Cu—Au—Zn), Copper-Zinc (Cu—Zn), Copper-Zinc-aluminum (Cu—Zn—Al), Copper-Zinc-Tin (Cu—Zn—Sn), Copper-Zinc-Xenon (Cu—Zn—Xe), Iron Beryllium (Fe3Be), Iron Platinum (Fe3Pt), Indium-Thallium (In—Tl), iron-manganese (Fe—Mn) Nickel-Titanium-Vanadium (Ni—Ti—V), Iron-Nickel-Titanium-Cobalt (Fe—Ni—Ti—Co) and Copper-Tin (Cu—Sn). See Schetsky, L. McDonald, “Shape Memory Alloys”, Encyclopedia of Chemical Technology (3rd ed.), John Wiley & Sons, 1982, vol. 20. pp. 726-736 for a full discussion of superelastic alloys. Preferably in some cases of elastic filament members, nitinol or other highly elastic metal is employed as the outer member, in an arrangement in which it is never stressed beyond the straight line portion of its stress strain curve. Other examples of metals suitable for the outer member include stainless steel or the precursor of superelastic alloys. Precursors of superelastic alloys are those alloys which have the same chemical constituents as superelastic alloys, but have not been processed to impart the superelastic property under the conditions of use. Such alloys are further described in co-owned and co-pending U.S. Ser. No. 07/507,375, filed Apr. 10, 1990, by R. Sahatjian (see also PCT application US91/02420) the entire contents of which is hereby incorporated by reference.
- The core material is preferably a continuous solid mass, but may also be in a powder-form. Typically, the core includes a metal that is relatively dense to enhance radiopacity. Preferably, the core metal has a density of about 9.9 g/cc or greater. Most preferably, the core is formed of tantalum (density=16.6 g/cc). Other preferred materials and their density include tungsten (19.3 g/cc), rhenium (21.2 g/cc), bismuth (9.9 g/cc), silver (16.49 g/cc), gold (19.3 g/cc), platinum (21.45 g/cc), and iridium (22.4 g/cc). Typically, the core is somewhat stiffer than the outer member. Preferably, the core metal has a low modulus of elasticity, e.g., preferably below about 550 GPa, e.g., such as tantalum (186 GPa). Generally, a smaller difference between the modulus of elasticity between the outer material and core results in a smaller variation of the modulus from that of the outer material in the filament of the invention. For larger differences, a smaller core may be used so as to produce a filament in which the elastic properties are dominated by the outer material.
- The outer member and core may be in many cross-sectional geometric configurations, such as circular, square, triangular, hexagonal, octagonal, trapezoidal and the geometrical configuration of the core may differ from that of the longitudinal member. For example, the outer member of a filament may be rectangular in cross-section with a rectangular core or triangular or hexagonal in cross-section with a circular core. A stent filament may also take on the form of tubing with a lumen within the core extending along the axis. A stent filament may also include successive layers of less dense outer material and more dense core material to form a multi-composite system of three layers or more from exterior to center. The core may extend intermittently along the axis in a desired pattern.
- The filament may be a draw-form member formed, for example, by drilling out the center of a relatively large rod of the outer member material to form a bore, positioning a rod of core material in the bore, sealing the ends of the bore, e.g., by crimping, and drawing the form through a series of dies of decreasing diameter until the desired outer diameter is achieved. The component may be heat treated to anneal, harden or impart superelastic properties. Other methods of formation are also possible, e.g., by coating the core with the desired outer material such as by electro- or electroless plating. The materials used in the outer member and core are also selected based on their workability for forming the filament, including factors such as machinability, for forming the longitudinal member into a tubular piece and the core member into a rod shaped piece, stability in gaseous environments at annealing temperatures, properties related to drawing, welding, forging; swaging, the ability to accept coatings such as adhesives, polymers, lubricants and practical aspects such as cost and availability.
- As evident from the above, the stents of the invention are preferably constructed by knitting a filament, most preferably on a circular knitting machine. Knitted metal stents are discussed, for example, in Strecker, U.S. Pat. No. 4,922,905. It will be appreciated that the stent may be formed from a composite metal filament by other means such as weaving, crocheting, or forming the filament into a spiral-spring form element. It will further be appreciated that the composite filament may be incorporated within a stent formed from conventional metal or non-metal materials (e.g. dacron in the case of an aortic graft) to contribute desirable properties such as strength and/or radiopacity. The stent may also be in the form of a metal member configured as other than a filament-form, e.g., a composite sheet form member in the form of a cuff or tube.
- The following example is illustrative of a stent filament.
- An elastic, radiopaque filament for use in a stent may be formed as follows. A 500 foot length of filament (0.0052 inch in diameter) having an outer member formed of a precursor of a nitinol (55% Ni/45% Ti) superelastic alloy and a core material of tantalum (0.00175 inch in diameter) is formed by drilling a 0.25 inch diameter bore in a 0.75 inch rod of the outer member material and providing in the drilled lumen a tantalum member of substantially matched outer diameter. The rod is mechanically forged in a standard hot forging and rolling apparatus, then hammered such that no substantial voids between the core and outer longitudinal member are present. One end of the rod is sealed and the opposite end is cold drawn longitudinally through a die to the final diameter. Initially, the outer member of the filament is the precursor of a superelastic alloy, i.e., it has not been heat treated to impart the superelastic property under the anticipated conditions of use.
- Referring to FIG. 6, load versus displacement curves are illustrated. (For clarity, curves C, D and A are offset, successively, 0.025 inch on the x-axis.) Curve A illustrates the filament as discussed in the above paragraph prior to heat annealing which induces the superelastic property; the filament exhibits substantially linear elastic strain as a function of stress to a break point z. Curves B, C, D illustrate stress/strain curves after annealing the filament at 460° C. for 3 minutes, 5 minutes and 15 minutes, respectively. As these curves illustrate, the superelastic nature of the filament is substantially preserved, as evidenced by the substantial plateaus (p) on the stress/strain curve, despite the presence of the tantalum core. Also as illustrated, the stress at which constant displacement occurs decreases with increasing annealing, as would be expected with a superelastic material. The mechanical properties of the filament, therefore, are dominated by the nitinol alloy, despite the presence of the tantalum core.
- Referring to Table I, the modulus of elasticity and plateau stress calculated based on stress-strain measurements as above, are compared for the filaments of the invention and a solid filament of Ni—Ti alloy.
TABLE 1 % Charge in Cored Ni—Ti Ta Cored Ni—Ti Filament Diameter .0038″ .0052″ — Area 1.134 × 10−5 in2 2.124 × 10−5 in2 — (Modulus of Elasticity) Precursor 5,401,300 psi 7,373,865 psi +27% 460° @ 3 mins 6,967,150 psi 6,657,000 psi −4.5% 460° @ 5 mins 5,381,160 psi 5,721,100 psi +6.0% 460° @ 10 mins 5,139,310 psi — — 460° @ 15 mins 5,143,960 psi 5,551,924 +7.4% Plateau Stress (loading) 460° @ 3 mins 101,400 psi 94,174 −7.2% 460° @ 5 mins 89,056 psi 84,757 −4.8% 460° @ 10 mins 79,357 psi — — 460° @ 15 mins 72,303 psi 75,339 psi +4.1% - As the results in Table I illustrate, the modulus of elasticity of the filaments of the invention was varied less than 30% compared to the solid Ni—Ti filament. The plateau stress of the filaments of the invention using a superelastic outer member was varied less than about 10% compared to a solid Ni—Ti superelastic filament. The composite filament formed as described exhibits about 30% or more enhanced x-ray visibility over a filament of the same thickness formed of solid nitinol.
- It will be understood that such filaments may be employed both in instances where the superelastic property is employed, and in instances where it is not (all stress within the straight line portion of the stress strain curve).
- The visibility of a knitted stent formed from the filament was greater than a comparison stent using a solid nitinol filament of larger (0.006 inch) diameter, yet using the stent of the invention, the force needed for radial compression of the stent was reduced compared to the stent formed of the thicker nitinol filament. Thus, radiopacity of the stent was enhanced while mechanical properties were dominated by the outer member, nitinol. Placement of the stent, as-described above, can be monitored by x-ray fluoroscopy.
- Preferably, filaments as described, dominated by the mechanical properties of an outer member, such as nitinol, and exhibiting generally satisfactory radiopacity have outer diameter (do) of about 0.008 to 0.0045 inch with a core, for example of tantalum, with diameter (dc) of about 0.0014 to 0.00195 inch.
- Other embodiments are in the following claims.
Claims (30)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/751,749 US20040138740A1 (en) | 1992-03-31 | 2004-01-05 | Tubular medical endoprostheses |
US12/421,777 US20100070025A1 (en) | 1992-03-31 | 2009-04-10 | Tubular medical endoprostheses |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86125392A | 1992-03-31 | 1992-03-31 | |
US91063192A | 1992-07-08 | 1992-07-08 | |
US28277694A | 1994-07-29 | 1994-07-29 | |
US47800795A | 1995-06-07 | 1995-06-07 | |
US08/955,268 US6290721B1 (en) | 1992-03-31 | 1997-10-21 | Tubular medical endoprostheses |
US09/076,520 US6287331B1 (en) | 1992-03-31 | 1998-05-12 | Tubular medical prosthesis |
US09/924,275 US7101392B2 (en) | 1992-03-31 | 2001-08-08 | Tubular medical endoprostheses |
US10/751,749 US20040138740A1 (en) | 1992-03-31 | 2004-01-05 | Tubular medical endoprostheses |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/924,275 Continuation US7101392B2 (en) | 1992-03-31 | 2001-08-08 | Tubular medical endoprostheses |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/421,777 Continuation US20100070025A1 (en) | 1992-03-31 | 2009-04-10 | Tubular medical endoprostheses |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040138740A1 true US20040138740A1 (en) | 2004-07-15 |
Family
ID=27557146
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/924,275 Expired - Fee Related US7101392B2 (en) | 1992-03-31 | 2001-08-08 | Tubular medical endoprostheses |
US10/751,749 Abandoned US20040138740A1 (en) | 1992-03-31 | 2004-01-05 | Tubular medical endoprostheses |
US12/421,777 Abandoned US20100070025A1 (en) | 1992-03-31 | 2009-04-10 | Tubular medical endoprostheses |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/924,275 Expired - Fee Related US7101392B2 (en) | 1992-03-31 | 2001-08-08 | Tubular medical endoprostheses |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/421,777 Abandoned US20100070025A1 (en) | 1992-03-31 | 2009-04-10 | Tubular medical endoprostheses |
Country Status (1)
Country | Link |
---|---|
US (3) | US7101392B2 (en) |
Families Citing this family (154)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US7018406B2 (en) * | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US20070043435A1 (en) * | 1999-11-17 | 2007-02-22 | Jacques Seguin | Non-cylindrical prosthetic valve system for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US7011676B2 (en) | 2002-09-05 | 2006-03-14 | Scimed Life Systems, Inc. | Flat knitted stent and method of making the same |
ATE531338T1 (en) | 2003-04-28 | 2011-11-15 | Kips Bay Medical Inc | ELASTIC VENOUS IMPLANT |
US7998188B2 (en) * | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
US20050131520A1 (en) * | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
BRPI0510107A (en) | 2004-04-23 | 2007-09-25 | 3F Therapeutics Inc | implantable protein valve |
US7993387B2 (en) * | 2004-05-14 | 2011-08-09 | Boston Scientific Scimed, Inc. | Stent with reduced weld profiles and a closed-end wire configuration |
US8617234B2 (en) * | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
EP2419048A4 (en) | 2004-05-25 | 2014-04-09 | Covidien Lp | Vascular stenting for aneurysms |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8628564B2 (en) | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
EP2626038B1 (en) | 2004-05-25 | 2016-09-14 | Covidien LP | Flexible vascular occluding device |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
CA2585284C (en) * | 2004-11-10 | 2013-07-23 | Boston Scientific Limited | Atraumatic stent with reduced deployment force, method for making the same and method and apparatus for deploying and positioning the stent |
US7641681B2 (en) * | 2004-12-28 | 2010-01-05 | Boston Scientific Scimed, Inc. | Low profile stent-graft attachment |
US20060149364A1 (en) * | 2004-12-31 | 2006-07-06 | Steven Walak | Low profile vascular graft |
US7727273B2 (en) * | 2005-01-13 | 2010-06-01 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
EP3260083B1 (en) | 2005-01-28 | 2022-12-14 | Boston Scientific Medical Device Limited | Implantable stent having a stent retrieval member |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US7618362B2 (en) * | 2005-03-28 | 2009-11-17 | Boston Scientific Scimed, Inc. | Spacer apparatus for radiation and ablation therapy |
US9265634B2 (en) * | 2005-05-13 | 2016-02-23 | Boston Scientific Scimed, Inc. | Integrated stent repositioning and retrieval loop |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
CN101180006B (en) | 2005-05-25 | 2010-09-22 | 切斯纳特医药技术公司 | System and method for delivering and deploying and occluding device within a vessel |
US7963988B2 (en) | 2005-06-23 | 2011-06-21 | Boston Scientific Scimed, Inc. | ePTFE lamination—resizing ePTFE tubing |
WO2007038540A1 (en) | 2005-09-26 | 2007-04-05 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
EP1769774A1 (en) * | 2005-10-03 | 2007-04-04 | Noureddine Frid | Radiopaque endoprostheses |
US7655035B2 (en) * | 2005-10-05 | 2010-02-02 | Boston Scientific Scimed, Inc. | Variable lamination of vascular graft |
EP3566742A1 (en) | 2005-10-13 | 2019-11-13 | Synthes GmbH | Drug-impregnated encasement |
US8152833B2 (en) | 2006-02-22 | 2012-04-10 | Tyco Healthcare Group Lp | Embolic protection systems having radiopaque filter mesh |
EP2004095B1 (en) | 2006-03-28 | 2019-06-12 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US20080097620A1 (en) | 2006-05-26 | 2008-04-24 | Nanyang Technological University | Implantable article, method of forming same and method for reducing thrombogenicity |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8052750B2 (en) | 2006-09-19 | 2011-11-08 | Medtronic Ventor Technologies Ltd | Valve prosthesis fixation techniques using sandwiching |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8784478B2 (en) | 2006-10-16 | 2014-07-22 | Medtronic Corevalve, Inc. | Transapical delivery system with ventruculo-arterial overlfow bypass |
US8105392B2 (en) | 2006-11-08 | 2012-01-31 | Boston Scientific Scimed, Inc. | Pyloric obesity valve |
US8747459B2 (en) | 2006-12-06 | 2014-06-10 | Medtronic Corevalve Llc | System and method for transapical delivery of an annulus anchored self-expanding valve |
CA2677648C (en) | 2007-02-16 | 2015-10-27 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
EP2175812A1 (en) | 2007-08-09 | 2010-04-21 | Boston Scientific Scimed, Inc. | Endoprosthesis holder |
US7785363B2 (en) * | 2007-08-15 | 2010-08-31 | Boston Scientific Scimed, Inc. | Skewed nodal-fibril ePTFE structure |
US20090048657A1 (en) * | 2007-08-15 | 2009-02-19 | Boston Scientific Scimed, Inc. | Preferentially varying-density ePTFE structure |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US9393137B2 (en) | 2007-09-24 | 2016-07-19 | Boston Scientific Scimed, Inc. | Method for loading a stent into a delivery system |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8062346B2 (en) * | 2007-12-21 | 2011-11-22 | Boston Scientific Scimed, Inc. | Flexible stent-graft device having patterned polymeric coverings |
US8623071B2 (en) * | 2008-01-07 | 2014-01-07 | DePuy Synthes Products, LLC | Radiopaque super-elastic intravascular stent |
US8628566B2 (en) | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
EP3744291B1 (en) | 2008-01-24 | 2022-11-23 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
EP2254512B1 (en) | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
BR112012021347A2 (en) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
EP3915525A1 (en) | 2008-02-28 | 2021-12-01 | Medtronic, Inc. | Prosthetic heart valve systems |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US10898620B2 (en) | 2008-06-20 | 2021-01-26 | Razmodics Llc | Composite stent having multi-axial flexibility and method of manufacture thereof |
US8206636B2 (en) | 2008-06-20 | 2012-06-26 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
US8206635B2 (en) | 2008-06-20 | 2012-06-26 | Amaranth Medical Pte. | Stent fabrication via tubular casting processes |
DE102008035772B4 (en) * | 2008-07-31 | 2015-02-12 | Airbus Defence and Space GmbH | Particle filter and manufacturing method thereof |
US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8137398B2 (en) * | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
ES2551694T3 (en) | 2008-12-23 | 2015-11-23 | Sorin Group Italia S.R.L. | Expandable prosthetic valve with anchoring appendages |
US8151682B2 (en) | 2009-01-26 | 2012-04-10 | Boston Scientific Scimed, Inc. | Atraumatic stent and method and apparatus for making the same |
EP2628465A1 (en) | 2009-04-27 | 2013-08-21 | Sorin Group Italia S.r.l. | Prosthetic vascular conduit |
US20100331960A1 (en) | 2009-06-30 | 2010-12-30 | Boston Scientific Scimed, Inc. | Endoprosthesis and endoprosthesis delivery system and method |
US9283305B2 (en) | 2009-07-09 | 2016-03-15 | Medtronic Vascular, Inc. | Hollow tubular drug eluting medical devices |
CA2764453C (en) | 2009-07-30 | 2017-06-27 | Boston Scientific Scimed, Inc. | Reconstrainment band with reduced removal interference |
US20110054589A1 (en) * | 2009-08-27 | 2011-03-03 | Boston Scientific Scimed, Inc. | Stent with variable cross section braiding filament and method for making same |
EP2475329B1 (en) | 2009-09-10 | 2015-12-02 | Boston Scientific Scimed, Inc. | Endoprosthesis with filament repositioning or retrieval member and guard structure |
US8678046B2 (en) | 2009-09-20 | 2014-03-25 | Medtronic Vascular, Inc. | Apparatus and methods for loading a drug eluting medical device |
US20110070358A1 (en) | 2009-09-20 | 2011-03-24 | Medtronic Vascular, Inc. | Method of forming hollow tubular drug eluting medical devices |
US8828474B2 (en) | 2009-09-20 | 2014-09-09 | Medtronic Vascular, Inc. | Apparatus and methods for loading a drug eluting medical device |
US8460745B2 (en) | 2009-09-20 | 2013-06-11 | Medtronic Vascular, Inc. | Apparatus and methods for loading a drug eluting medical device |
WO2011034768A1 (en) | 2009-09-21 | 2011-03-24 | Boston Scientific Scimed, Inc. | Integrated stent retrieval loop adapted for snare removal and/or optimized purse stringing |
US8992553B2 (en) * | 2009-10-01 | 2015-03-31 | Cardioniti | Cutting balloon assembly and method of manufacturing thereof |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US10052220B2 (en) | 2009-10-09 | 2018-08-21 | Boston Scientific Scimed, Inc. | Stomach bypass for the treatment of obesity |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US20110270405A1 (en) | 2010-04-30 | 2011-11-03 | Boston Scientific Scimed, Inc. | Duodenal Metabolic Stent |
US10398540B2 (en) | 2010-04-30 | 2019-09-03 | Boston Scientific Scimed, Inc. | Stent for repair of anastomasis surgery leaks |
US9155643B2 (en) | 2010-04-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Apparatus and method for manufacturing a single wire stent |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
AU2011257298B2 (en) | 2010-05-25 | 2014-07-31 | Jenavalve Technology Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
CN103118629A (en) | 2010-09-01 | 2013-05-22 | 美敦力瓦斯科尔勒戈尔韦有限公司 | Prosthetic valve support structure |
US8333801B2 (en) | 2010-09-17 | 2012-12-18 | Medtronic Vascular, Inc. | Method of Forming a Drug-Eluting Medical Device |
US8616040B2 (en) | 2010-09-17 | 2013-12-31 | Medtronic Vascular, Inc. | Method of forming a drug-eluting medical device |
US8632846B2 (en) | 2010-09-17 | 2014-01-21 | Medtronic Vascular, Inc. | Apparatus and methods for loading a drug eluting medical device |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
ES2641902T3 (en) | 2011-02-14 | 2017-11-14 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
TWI590843B (en) | 2011-12-28 | 2017-07-11 | 信迪思有限公司 | Films and methods of manufacture |
EP2842517A1 (en) | 2011-12-29 | 2015-03-04 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
US9119736B2 (en) | 2012-01-27 | 2015-09-01 | Medtronic Vascular, Inc. | Hollow drug-filled stent and method of forming hollow drug-filled stent |
US9345596B2 (en) | 2012-02-23 | 2016-05-24 | Medtronic Vascular, Inc. | Method of forming a nitinol stent |
US9358370B2 (en) | 2012-03-12 | 2016-06-07 | Medtronic Vascular, Inc. | Guidewire with integral radiopaque markers |
US8998977B2 (en) | 2012-04-13 | 2015-04-07 | Medtronic Vascular, Inc. | Hollow drug-filled stent and method of forming hollow drug-filled stent |
US9649208B2 (en) | 2012-04-13 | 2017-05-16 | Medtronic Vascular, Inc. | Hollow drug-filled stent and method of forming hollow drug-filled stent |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
DE102013100984B4 (en) * | 2013-01-31 | 2019-03-21 | Acandis Gmbh | Grid mesh for a medical implant or instrument, implant and instrument with such a mesh and set with such an implant or instrument |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
WO2014151906A1 (en) | 2013-03-14 | 2014-09-25 | Medtronic Vascular Inc. | Method for manufacturing a stent and stent manufactured thereby |
JP6561044B2 (en) | 2013-05-03 | 2019-08-14 | メドトロニック,インコーポレイテッド | Valve transfer tool |
CN105555328B (en) | 2013-06-21 | 2019-01-11 | 德普伊新特斯产品公司 | film and manufacturing method |
EP4098226A1 (en) | 2013-08-30 | 2022-12-07 | JenaValve Technology, Inc. | Endoprosthesis comprising a radially collapsible frame and a prosthetic valve |
WO2015160998A2 (en) | 2014-04-17 | 2015-10-22 | Abbott Cardiovascular Systems Inc. | Coatings for braided medical devices and methods of forming same |
EP3193780A1 (en) | 2014-09-18 | 2017-07-26 | Boston Scientific Scimed Inc. | Device allowing pyloric sphincter to normally function for bariatric stents |
EP3288495B1 (en) | 2015-05-01 | 2019-09-25 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10568754B2 (en) | 2016-05-13 | 2020-02-25 | Boston Scientific Scimed, Inc. | Protective apparatus for use in gastrointestinal tract |
US10470904B2 (en) | 2016-05-18 | 2019-11-12 | Boston Scientific Scimed, Inc. | Stent retrieval system |
WO2017206155A1 (en) * | 2016-06-03 | 2017-12-07 | 浦易(上海)生物技术有限公司 | Weaving method for nasal sinus stent and stent obtained thereof |
WO2018089696A1 (en) | 2016-11-10 | 2018-05-17 | Medtronic Vascular Inc. | Drug-filled stent with filaments for increased lumen surface area and method of manufacture thereof |
WO2018089705A1 (en) | 2016-11-10 | 2018-05-17 | Medtronic Vascular Inc. | Drug-filled stents to prevent vessel micro-injuries and methods of manufacture thereof |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
WO2019036283A1 (en) | 2017-08-14 | 2019-02-21 | Boston Scientific Scimed, Inc. | Medical stents |
EP4238539A3 (en) | 2017-10-25 | 2023-10-18 | Boston Scientific Scimed, Inc. | Stent with atraumatic spacer |
CN112437649A (en) | 2018-05-23 | 2021-03-02 | 索林集团意大利有限责任公司 | Heart valve prosthesis |
EP3890662A1 (en) | 2018-12-04 | 2021-10-13 | Boston Scientific Scimed Inc. | Device for anastomotic bypass |
US11389286B2 (en) | 2018-12-05 | 2022-07-19 | Boston Scientific Scimed, Inc. | Esophageal atresia bridge device |
US11364030B2 (en) | 2019-02-15 | 2022-06-21 | Boston Scientific Scimed, Inc. | Medical device for treating esophageal atresia |
WO2021101861A1 (en) | 2019-11-18 | 2021-05-27 | Boston Scientific Scimed, Inc. | Stent with improved anti-migration properties |
EP4192401A1 (en) | 2020-09-21 | 2023-06-14 | Boston Scientific Scimed Inc. | Stents with liner facilitating stent removal |
WO2022066468A1 (en) | 2020-09-24 | 2022-03-31 | Boston Scientific Scimed, Inc. | Stent devices and methods to increase patency of a body opening |
Citations (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3446166A (en) * | 1966-10-05 | 1969-05-27 | Southern Textile Machinery Co | Apparatus for inspecting and sewing stockings |
US3558066A (en) * | 1969-01-21 | 1971-01-26 | Howard Alliger | Ultrasonic extraction of viable antigens from gram positive bacteria |
US3562024A (en) * | 1967-12-04 | 1971-02-09 | Standard Pressed Steel Co | Cobalt-nickel base alloys containing chromium and molybdenum |
US3805787A (en) * | 1972-06-16 | 1974-04-23 | Surgical Design Corp | Ultrasonic surgical instrument |
US3861391A (en) * | 1972-07-02 | 1975-01-21 | Blackstone Corp | Apparatus for disintegration of urinary calculi |
US3941122A (en) * | 1974-04-08 | 1976-03-02 | Bolt Beranek And Newman, Inc. | High frequency ultrasonic process and apparatus for selectively dissolving and removing unwanted solid and semi-solid materials and the like |
US3942519A (en) * | 1972-12-26 | 1976-03-09 | Ultrasonic Systems, Inc. | Method of ultrasonic cryogenic cataract removal |
US3956826A (en) * | 1974-03-19 | 1976-05-18 | Cavitron Corporation | Ultrasonic device and method |
US4023557A (en) * | 1975-11-05 | 1977-05-17 | Uop Inc. | Solar collector utilizing copper lined aluminum tubing and method of making such tubing |
US4188952A (en) * | 1973-12-28 | 1980-02-19 | Loschilov Vladimir I | Surgical instrument for ultrasonic separation of biological tissue |
US4202349A (en) * | 1978-04-24 | 1980-05-13 | Jones James W | Radiopaque vessel markers |
US4370131A (en) * | 1977-06-24 | 1983-01-25 | Surgical Design | Ultrasonic transducer tips |
US4380574A (en) * | 1977-05-09 | 1983-04-19 | Bbc Brown, Boveri & Company, Ltd. | High-damping composite material |
US4425115A (en) * | 1977-12-19 | 1984-01-10 | Wuchinich David G | Ultrasonic resonant vibrator |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4428379A (en) * | 1982-01-07 | 1984-01-31 | Technicare Corporation | Passive ultrasound needle probe locator |
US4431006A (en) * | 1982-01-07 | 1984-02-14 | Technicare Corporation | Passive ultrasound needle probe locator |
US4504268A (en) * | 1981-11-10 | 1985-03-12 | Intermedicate Gmbh | Stiffening core for a catheter tube |
US4518444A (en) * | 1982-02-05 | 1985-05-21 | Bbc Brown, Boveri & Company, Limited | Material which is at least partially made from a constituent having a one-way shape memory effect and process to produce said material |
US4517793A (en) * | 1983-08-23 | 1985-05-21 | Vernon-Carus Limited | Radio opaque fibre |
US4572184A (en) * | 1983-10-28 | 1986-02-25 | Blackstone Corporation | Wave guide attachment means and methods |
US4577637A (en) * | 1984-07-13 | 1986-03-25 | Argon Medical Corp. | Flexible metal radiopaque indicator and plugs for catheters |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4654092A (en) * | 1983-11-15 | 1987-03-31 | Raychem Corporation | Nickel-titanium-base shape-memory alloy composite structure |
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4657024A (en) * | 1980-02-04 | 1987-04-14 | Teleflex Incorporated | Medical-surgical catheter |
US4719916A (en) * | 1983-10-03 | 1988-01-19 | Biagio Ravo | Intraintestinal bypass tube |
US4724846A (en) * | 1986-01-10 | 1988-02-16 | Medrad, Inc. | Catheter guide wire assembly |
US4731084A (en) * | 1986-03-14 | 1988-03-15 | Richards Medical Company | Prosthetic ligament |
US4732152A (en) * | 1984-12-05 | 1988-03-22 | Medinvent S.A. | Device for implantation and a method of implantation in a vessel using such device |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4796637A (en) * | 1987-06-17 | 1989-01-10 | Victory Engineering Company | Radiopaque marker for stereotaxic catheter |
US4800890A (en) * | 1984-12-28 | 1989-01-31 | Cramer Bernhard M | Steerable guide wire for catheters |
US4808246A (en) * | 1983-03-14 | 1989-02-28 | Bbc Brown, Boveri & Company Limited | Composite material in rod, tube, strip, sheet or plate shape with reversible thermomechanical properties and process for its production |
US4816018A (en) * | 1985-08-02 | 1989-03-28 | Ultramed Corporation | Ultrasonic probe tip |
US4817600A (en) * | 1987-05-22 | 1989-04-04 | Medi-Tech, Inc. | Implantable filter |
US4819618A (en) * | 1986-08-18 | 1989-04-11 | Liprie Sam F | Iridium/platinum implant, method of encapsulation, and method of implantation |
US4823793A (en) * | 1985-10-30 | 1989-04-25 | The United States Of America As Represented By The Administrator Of The National Aeronuautics & Space Administration | Cutting head for ultrasonic lithotripsy |
US4830262A (en) * | 1985-11-19 | 1989-05-16 | Nippon Seisen Co., Ltd. | Method of making titanium-nickel alloys by consolidation of compound material |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US4830023A (en) * | 1987-11-27 | 1989-05-16 | Medi-Tech, Incorporated | Medical guidewire |
US4834747A (en) * | 1984-11-08 | 1989-05-30 | Medinvent S.A. | Method of producing a multilayered prosthesis material and the material obtained |
US4892541A (en) * | 1982-11-29 | 1990-01-09 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4899733A (en) * | 1988-12-19 | 1990-02-13 | Blackstone Ultrasonic, Inc. | Device and technique for transurethral ultrasonic lithotripsy using a flexible ureteroscope |
US4906241A (en) * | 1987-11-30 | 1990-03-06 | Boston Scientific Corporation | Dilation balloon |
US4907572A (en) * | 1988-04-14 | 1990-03-13 | Urological Instruments Research, Inc. | Vibrational method for accelerating passage of stones from ureter |
US4920954A (en) * | 1988-08-05 | 1990-05-01 | Sonic Needle Corporation | Ultrasonic device for applying cavitation forces |
US4922924A (en) * | 1989-04-27 | 1990-05-08 | C. R. Bard, Inc. | Catheter guidewire with varying radiopacity |
US4922905A (en) * | 1985-11-30 | 1990-05-08 | Strecker Ernst P | Dilatation catheter |
US4925445A (en) * | 1983-09-16 | 1990-05-15 | Fuji Terumo Co., Ltd. | Guide wire for catheter |
US4980964A (en) * | 1988-08-19 | 1991-01-01 | Jan Boeke | Superconducting wire |
US4984581A (en) * | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
US4990151A (en) * | 1988-09-28 | 1991-02-05 | Medinvent S.A. | Device for transluminal implantation or extraction |
US4989608A (en) * | 1987-07-02 | 1991-02-05 | Ratner Adam V | Device construction and method facilitating magnetic resonance imaging of foreign objects in a body |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US4995878A (en) * | 1988-07-15 | 1991-02-26 | Rai Dinker B | Method for descending venography |
US5001825A (en) * | 1988-11-03 | 1991-03-26 | Cordis Corporation | Catheter guidewire fabrication method |
US5003989A (en) * | 1989-05-11 | 1991-04-02 | Advanced Cardiovascular Systems, Inc. | Steerable dilation catheter |
US5003987A (en) * | 1987-09-11 | 1991-04-02 | Grinwald Paul M | Method and apparatus for enhanced drug permeation of skin |
US5012797A (en) * | 1990-01-08 | 1991-05-07 | Montefiore Hospital Association Of Western Pennsylvania | Method for removing skin wrinkles |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5015183A (en) * | 1989-08-07 | 1991-05-14 | Fenick Thomas J | Locating device and method of placing a tooth implant |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5019085A (en) * | 1988-10-25 | 1991-05-28 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US5092877A (en) * | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US5095915A (en) * | 1990-03-19 | 1992-03-17 | Target Therapeutics | Guidewire with flexible distal tip |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5109830A (en) * | 1990-04-10 | 1992-05-05 | Candela Laser Corporation | Apparatus for navigation of body cavities |
US5111829A (en) * | 1989-06-28 | 1992-05-12 | Boston Scientific Corporation | Steerable highly elongated guidewire |
US5176617A (en) * | 1989-12-11 | 1993-01-05 | Medical Innovative Technologies R & D Limited Partnership | Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct |
US5197978A (en) * | 1991-04-26 | 1993-03-30 | Advanced Coronary Technology, Inc. | Removable heat-recoverable tissue supporting device |
US5201901A (en) * | 1987-10-08 | 1993-04-13 | Terumo Kabushiki Kaisha | Expansion unit and apparatus for expanding tubular organ lumen |
US5207706A (en) * | 1988-10-05 | 1993-05-04 | Menaker M D Gerald | Method and means for gold-coating implantable intravascular devices |
US5213111A (en) * | 1991-07-10 | 1993-05-25 | Cook Incorporated | Composite wire guide construction |
US5276455A (en) * | 1991-05-24 | 1994-01-04 | The Boeing Company | Packaging architecture for phased arrays |
US5304140A (en) * | 1987-08-28 | 1994-04-19 | Terumo Kabushiki Kaisha | Catheter for introduction into blood vessel |
US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5397293A (en) * | 1992-11-25 | 1995-03-14 | Misonix, Inc. | Ultrasonic device with sheath and transverse motion damping |
US5489227A (en) * | 1993-09-03 | 1996-02-06 | Sanshin Kogyo Kabushiki Kaisha | Protective cowling for outboard motor |
US5496330A (en) * | 1993-02-19 | 1996-03-05 | Boston Scientific Corporation | Surgical extractor with closely angularly spaced individual filaments |
US5498236A (en) * | 1992-05-19 | 1996-03-12 | Dubrul; Will R. | Vibrating catheter |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5628787A (en) * | 1993-01-19 | 1997-05-13 | Schneider (Usa) Inc. | Clad composite stent |
US5725570A (en) * | 1992-03-31 | 1998-03-10 | Boston Scientific Corporation | Tubular medical endoprostheses |
US5725549A (en) * | 1994-03-11 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US5879382A (en) * | 1989-08-24 | 1999-03-09 | Boneau; Michael D. | Endovascular support device and method |
US5891191A (en) * | 1996-04-30 | 1999-04-06 | Schneider (Usa) Inc | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US5891193A (en) * | 1993-11-04 | 1999-04-06 | C.R. Bard, Inc. | Non-migrating vascular prosthesis and minimally invasive placement system therefor |
US6015432A (en) * | 1998-02-25 | 2000-01-18 | Cordis Corporation | Wire reinforced vascular prosthesis |
US6017362A (en) * | 1994-04-01 | 2000-01-25 | Gore Enterprise Holdings, Inc. | Folding self-expandable intravascular stent |
US6027528A (en) * | 1996-05-28 | 2000-02-22 | Cordis Corporation | Composite material endoprosthesis |
US6033719A (en) * | 1996-04-25 | 2000-03-07 | Medtronic, Inc. | Method for covalent attachment of biomolecules to surfaces of medical devices |
US6206915B1 (en) * | 1998-09-29 | 2001-03-27 | Medtronic Ave, Inc. | Drug storing and metering stent |
US6527802B1 (en) * | 1993-01-19 | 2003-03-04 | Scimed Life Systems, Inc. | Clad composite stent |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3335443A (en) | 1967-08-15 | Ultrasonic brush | ||
US2524661A (en) | 1947-05-03 | 1950-10-03 | Elgin Nat Watch Co | Alloy having high elastic strengths |
US3196876A (en) | 1961-05-10 | 1965-07-27 | Maurice M Miller | Dilator |
NL145136C (en) | 1967-07-25 | 1900-01-01 | ||
US3528410A (en) | 1968-09-16 | 1970-09-15 | Surgical Design Corp | Ultrasonic method for retinal attachment |
US3584327A (en) | 1969-04-04 | 1971-06-15 | Fibra Sonics | Ultrasonic transmission system |
US3605750A (en) | 1969-04-07 | 1971-09-20 | David S Sheridan | X-ray tip catheter |
US3618614A (en) | 1969-05-06 | 1971-11-09 | Scient Tube Products Inc | Nontoxic radiopaque multiwall medical-surgical tubings |
US3618594A (en) | 1970-04-06 | 1971-11-09 | Surgical Design Corp | Ultrasonic apparatus for retinal reattachment |
US3930173A (en) | 1971-06-15 | 1975-12-30 | Surgical Design Corp | Ultrasonic transducers |
DE2219790C3 (en) | 1972-04-22 | 1974-11-07 | R Pohlman | Device for generating brittle fractures in hard stones |
US3830240A (en) | 1972-07-02 | 1974-08-20 | Blackstone Corp | Method and apparatus for disintegration of urinary calculi |
US3749086A (en) | 1972-07-24 | 1973-07-31 | Medical Evaluation Devices & I | Spring guide with flexible distal tip |
DE2242863A1 (en) | 1972-08-31 | 1974-03-14 | Karl Storz | SURGICAL ELEMENT FOR CRUSHING STONES IN THE HUMAN BODY BY ULTRASOUND |
US4041931A (en) | 1976-05-17 | 1977-08-16 | Elliott Donald P | Radiopaque anastomosis marker |
US4178935A (en) | 1977-07-21 | 1979-12-18 | Ediny Jury G | Method and apparatus for disintegration of urinary concretions |
CA1153264A (en) | 1979-02-08 | 1983-09-06 | Hidenaga Yoshimura | Medical vascular guide wire and self-guiding type catheter |
US4281419A (en) | 1979-12-10 | 1981-08-04 | Richards Manufacturing Company, Inc. | Middle ear ossicular replacement prosthesis having a movable joint |
US4295464A (en) | 1980-03-21 | 1981-10-20 | Shihata Alfred A | Ureteric stone extractor with two ballooned catheters |
FI59720C (en) * | 1980-04-02 | 1981-10-12 | Outokumpu Oy | COUPLING FOER LIVMODERINLAEGG SAMT FOERFARANDE FOER FRAMSTAELLNING AV DENSAMMA |
DE3019996A1 (en) | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | HOHLORGAN |
EP0051975B1 (en) | 1980-11-07 | 1987-03-11 | David Baram | A valve |
US4465481A (en) | 1981-02-26 | 1984-08-14 | Innovative Surgical Products, Inc. | Single piece wound drain catheter |
US4406284B1 (en) | 1981-03-20 | 1997-11-18 | Surgical Design Corp | Ultrasonic handpiece design |
US4417578A (en) | 1981-03-20 | 1983-11-29 | Surgical Design | Ultrasonic transducer with energy shielding |
BR8208063A (en) | 1981-09-16 | 1984-01-10 | Hans Ivar Wallsten | DEVICE FOR APPLICATION IN BLOOD VESSELS OR OTHER DIFFICULT ACCESS PLACES AND THEIR USE |
GB2116045B (en) | 1982-03-04 | 1985-01-23 | Wolf Gmbh Richard | Piezoelectric transducers having a curved tubular shaft for disintegrating calculi |
GB2116046B (en) | 1982-03-04 | 1985-05-22 | Wolf Gmbh Richard | Apparatus for disintegrating and removing calculi |
US4474180A (en) | 1982-05-13 | 1984-10-02 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Apparatus for disintegrating kidney stones |
US4464176A (en) | 1982-06-04 | 1984-08-07 | Mallinckrodt, Inc. | Blood vessel catheter for medicine delivery and method of manufacture |
US4535759A (en) | 1982-09-30 | 1985-08-20 | Cabot Medical Corporation | Ultrasonic medical instrument |
US4680031A (en) | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4615331A (en) | 1983-06-28 | 1986-10-07 | Sterimed Gesellschaft Fur Medizinischen Bedarf Mbh | Medical instruments with aid to introduction |
JPS6082648A (en) | 1983-10-08 | 1985-05-10 | Agency Of Ind Science & Technol | Process for forming material having high strength and difficult processability |
US4848348A (en) | 1983-11-14 | 1989-07-18 | Minnesota Mining And Manufacturing Company | Coated films |
US5275622A (en) * | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
JPS60126170A (en) | 1983-12-14 | 1985-07-05 | テルモ株式会社 | Catheter and its production |
SE452404B (en) | 1984-02-03 | 1987-11-30 | Medinvent Sa | MULTILAYER PROTEST MATERIAL AND PROCEDURE FOR ITS MANUFACTURING |
CA1237482A (en) | 1984-03-09 | 1988-05-31 | Frank B. Stiles | Catheter for effecting removal of obstructions from a biological duct |
US4697595A (en) | 1984-07-24 | 1987-10-06 | Telectronics N.V. | Ultrasonically marked cardiac catheters |
YU132884A (en) | 1984-07-26 | 1987-12-31 | Branko Breyer | Electrode cateter with ultrasonic marking |
US4602633A (en) | 1984-11-16 | 1986-07-29 | Blackstone Corporation | Methods and apparatus for disintegration of urinary calculi under direct vision |
US4629458A (en) | 1985-02-26 | 1986-12-16 | Cordis Corporation | Reinforcing structure for cardiovascular graft |
CH665784A5 (en) | 1985-03-21 | 1988-06-15 | Hansen Dieter Ag | ULTRASONIC MACHINE TOOL. |
SE450809B (en) | 1985-04-10 | 1987-08-03 | Medinvent Sa | PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS |
SE447061B (en) | 1985-06-10 | 1986-10-27 | Medinvent Sa | INFO DEVICE, SPEC FOR IMPLEMENTATION IN A LIVE ORGANISM |
US4750488A (en) | 1986-05-19 | 1988-06-14 | Sonomed Technology, Inc. | Vibration apparatus preferably for endoscopic ultrasonic aspirator |
US4750902A (en) | 1985-08-28 | 1988-06-14 | Sonomed Technology, Inc. | Endoscopic ultrasonic aspirators |
US4698058A (en) | 1985-10-15 | 1987-10-06 | Albert R. Greenfeld | Ultrasonic self-cleaning catheter system for indwelling drains and medication supply |
US4748986A (en) | 1985-11-26 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Floppy guide wire with opaque tip |
US4681110A (en) | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
WO1987004935A1 (en) | 1986-02-24 | 1987-08-27 | Fischell Robert | An intravascular stent and percutaneous insertion system |
US4867173A (en) | 1986-06-30 | 1989-09-19 | Meadox Surgimed A/S | Steerable guidewire |
SE454482B (en) | 1986-09-30 | 1988-05-09 | Medinvent Sa | DEVICE FOR IMPLANTATION |
SE455834B (en) | 1986-10-31 | 1988-08-15 | Medinvent Sa | DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS |
US4793348A (en) | 1986-11-15 | 1988-12-27 | Palmaz Julio C | Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation |
US4748971A (en) | 1987-01-30 | 1988-06-07 | German Borodulin | Vibrational apparatus for accelerating passage of stones from ureter |
US4870953A (en) | 1987-11-13 | 1989-10-03 | Donmicheal T Anthony | Intravascular ultrasonic catheter/probe and method for treating intravascular blockage |
US4846186A (en) | 1988-01-12 | 1989-07-11 | Cordis Corporation | Flexible guidewire |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US5059166A (en) * | 1989-12-11 | 1991-10-22 | Medical Innovative Technologies R & D Limited Partnership | Intra-arterial stent with the capability to inhibit intimal hyperplasia |
US5123917A (en) * | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
US5360440A (en) * | 1992-03-09 | 1994-11-01 | Boston Scientific Corporation | In situ apparatus for generating an electrical current in a biological environment |
US6387123B1 (en) * | 1999-10-13 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque core |
US20080140176A1 (en) * | 2006-10-18 | 2008-06-12 | Krause Arthur A | Medical stent and devices for localized treatment of disease |
-
2001
- 2001-08-08 US US09/924,275 patent/US7101392B2/en not_active Expired - Fee Related
-
2004
- 2004-01-05 US US10/751,749 patent/US20040138740A1/en not_active Abandoned
-
2009
- 2009-04-10 US US12/421,777 patent/US20100070025A1/en not_active Abandoned
Patent Citations (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3446166A (en) * | 1966-10-05 | 1969-05-27 | Southern Textile Machinery Co | Apparatus for inspecting and sewing stockings |
US3562024A (en) * | 1967-12-04 | 1971-02-09 | Standard Pressed Steel Co | Cobalt-nickel base alloys containing chromium and molybdenum |
US3558066A (en) * | 1969-01-21 | 1971-01-26 | Howard Alliger | Ultrasonic extraction of viable antigens from gram positive bacteria |
US3805787A (en) * | 1972-06-16 | 1974-04-23 | Surgical Design Corp | Ultrasonic surgical instrument |
US3861391A (en) * | 1972-07-02 | 1975-01-21 | Blackstone Corp | Apparatus for disintegration of urinary calculi |
US3942519A (en) * | 1972-12-26 | 1976-03-09 | Ultrasonic Systems, Inc. | Method of ultrasonic cryogenic cataract removal |
US4188952A (en) * | 1973-12-28 | 1980-02-19 | Loschilov Vladimir I | Surgical instrument for ultrasonic separation of biological tissue |
US3956826A (en) * | 1974-03-19 | 1976-05-18 | Cavitron Corporation | Ultrasonic device and method |
US3941122A (en) * | 1974-04-08 | 1976-03-02 | Bolt Beranek And Newman, Inc. | High frequency ultrasonic process and apparatus for selectively dissolving and removing unwanted solid and semi-solid materials and the like |
US4023557A (en) * | 1975-11-05 | 1977-05-17 | Uop Inc. | Solar collector utilizing copper lined aluminum tubing and method of making such tubing |
US4380574A (en) * | 1977-05-09 | 1983-04-19 | Bbc Brown, Boveri & Company, Ltd. | High-damping composite material |
US4370131A (en) * | 1977-06-24 | 1983-01-25 | Surgical Design | Ultrasonic transducer tips |
US4425115A (en) * | 1977-12-19 | 1984-01-10 | Wuchinich David G | Ultrasonic resonant vibrator |
US4202349A (en) * | 1978-04-24 | 1980-05-13 | Jones James W | Radiopaque vessel markers |
US4657024A (en) * | 1980-02-04 | 1987-04-14 | Teleflex Incorporated | Medical-surgical catheter |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4504268A (en) * | 1981-11-10 | 1985-03-12 | Intermedicate Gmbh | Stiffening core for a catheter tube |
US4431006A (en) * | 1982-01-07 | 1984-02-14 | Technicare Corporation | Passive ultrasound needle probe locator |
US4428379A (en) * | 1982-01-07 | 1984-01-31 | Technicare Corporation | Passive ultrasound needle probe locator |
US4518444A (en) * | 1982-02-05 | 1985-05-21 | Bbc Brown, Boveri & Company, Limited | Material which is at least partially made from a constituent having a one-way shape memory effect and process to produce said material |
US4655771A (en) * | 1982-04-30 | 1987-04-07 | Shepherd Patents S.A. | Prosthesis comprising an expansible or contractile tubular body |
US4655771B1 (en) * | 1982-04-30 | 1996-09-10 | Medinvent Ams Sa | Prosthesis comprising an expansible or contractile tubular body |
US4892541A (en) * | 1982-11-29 | 1990-01-09 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4808246A (en) * | 1983-03-14 | 1989-02-28 | Bbc Brown, Boveri & Company Limited | Composite material in rod, tube, strip, sheet or plate shape with reversible thermomechanical properties and process for its production |
US4517793A (en) * | 1983-08-23 | 1985-05-21 | Vernon-Carus Limited | Radio opaque fibre |
US4925445A (en) * | 1983-09-16 | 1990-05-15 | Fuji Terumo Co., Ltd. | Guide wire for catheter |
US4719916A (en) * | 1983-10-03 | 1988-01-19 | Biagio Ravo | Intraintestinal bypass tube |
US4572184A (en) * | 1983-10-28 | 1986-02-25 | Blackstone Corporation | Wave guide attachment means and methods |
US4654092A (en) * | 1983-11-15 | 1987-03-31 | Raychem Corporation | Nickel-titanium-base shape-memory alloy composite structure |
US4577637A (en) * | 1984-07-13 | 1986-03-25 | Argon Medical Corp. | Flexible metal radiopaque indicator and plugs for catheters |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4834747A (en) * | 1984-11-08 | 1989-05-30 | Medinvent S.A. | Method of producing a multilayered prosthesis material and the material obtained |
US4732152A (en) * | 1984-12-05 | 1988-03-22 | Medinvent S.A. | Device for implantation and a method of implantation in a vessel using such device |
US4800890A (en) * | 1984-12-28 | 1989-01-31 | Cramer Bernhard M | Steerable guide wire for catheters |
US4816018A (en) * | 1985-08-02 | 1989-03-28 | Ultramed Corporation | Ultrasonic probe tip |
US4823793A (en) * | 1985-10-30 | 1989-04-25 | The United States Of America As Represented By The Administrator Of The National Aeronuautics & Space Administration | Cutting head for ultrasonic lithotripsy |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665B1 (en) * | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4830262A (en) * | 1985-11-19 | 1989-05-16 | Nippon Seisen Co., Ltd. | Method of making titanium-nickel alloys by consolidation of compound material |
US4922905A (en) * | 1985-11-30 | 1990-05-08 | Strecker Ernst P | Dilatation catheter |
US4724846A (en) * | 1986-01-10 | 1988-02-16 | Medrad, Inc. | Catheter guide wire assembly |
US4731084A (en) * | 1986-03-14 | 1988-03-15 | Richards Medical Company | Prosthetic ligament |
US4819618A (en) * | 1986-08-18 | 1989-04-11 | Liprie Sam F | Iridium/platinum implant, method of encapsulation, and method of implantation |
US4817600A (en) * | 1987-05-22 | 1989-04-04 | Medi-Tech, Inc. | Implantable filter |
US4796637A (en) * | 1987-06-17 | 1989-01-10 | Victory Engineering Company | Radiopaque marker for stereotaxic catheter |
US4989608A (en) * | 1987-07-02 | 1991-02-05 | Ratner Adam V | Device construction and method facilitating magnetic resonance imaging of foreign objects in a body |
US5304140A (en) * | 1987-08-28 | 1994-04-19 | Terumo Kabushiki Kaisha | Catheter for introduction into blood vessel |
US5003987A (en) * | 1987-09-11 | 1991-04-02 | Grinwald Paul M | Method and apparatus for enhanced drug permeation of skin |
US5201901A (en) * | 1987-10-08 | 1993-04-13 | Terumo Kabushiki Kaisha | Expansion unit and apparatus for expanding tubular organ lumen |
US4830023A (en) * | 1987-11-27 | 1989-05-16 | Medi-Tech, Incorporated | Medical guidewire |
US4906241A (en) * | 1987-11-30 | 1990-03-06 | Boston Scientific Corporation | Dilation balloon |
US4907572A (en) * | 1988-04-14 | 1990-03-13 | Urological Instruments Research, Inc. | Vibrational method for accelerating passage of stones from ureter |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US4995878A (en) * | 1988-07-15 | 1991-02-26 | Rai Dinker B | Method for descending venography |
US4920954A (en) * | 1988-08-05 | 1990-05-01 | Sonic Needle Corporation | Ultrasonic device for applying cavitation forces |
US4980964A (en) * | 1988-08-19 | 1991-01-01 | Jan Boeke | Superconducting wire |
US4980964B1 (en) * | 1988-08-19 | 1993-02-09 | Boeke Jan | |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5092877A (en) * | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US4990151A (en) * | 1988-09-28 | 1991-02-05 | Medinvent S.A. | Device for transluminal implantation or extraction |
US5207706A (en) * | 1988-10-05 | 1993-05-04 | Menaker M D Gerald | Method and means for gold-coating implantable intravascular devices |
US4984581A (en) * | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
US5019085A (en) * | 1988-10-25 | 1991-05-28 | Cordis Corporation | Apparatus and method for placement of a stent within a subject vessel |
US5001825A (en) * | 1988-11-03 | 1991-03-26 | Cordis Corporation | Catheter guidewire fabrication method |
US4899733A (en) * | 1988-12-19 | 1990-02-13 | Blackstone Ultrasonic, Inc. | Device and technique for transurethral ultrasonic lithotripsy using a flexible ureteroscope |
US4922924A (en) * | 1989-04-27 | 1990-05-08 | C. R. Bard, Inc. | Catheter guidewire with varying radiopacity |
US5003989A (en) * | 1989-05-11 | 1991-04-02 | Advanced Cardiovascular Systems, Inc. | Steerable dilation catheter |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5111829A (en) * | 1989-06-28 | 1992-05-12 | Boston Scientific Corporation | Steerable highly elongated guidewire |
US5015183A (en) * | 1989-08-07 | 1991-05-14 | Fenick Thomas J | Locating device and method of placing a tooth implant |
US5879382A (en) * | 1989-08-24 | 1999-03-09 | Boneau; Michael D. | Endovascular support device and method |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5176617A (en) * | 1989-12-11 | 1993-01-05 | Medical Innovative Technologies R & D Limited Partnership | Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct |
US5012797A (en) * | 1990-01-08 | 1991-05-07 | Montefiore Hospital Association Of Western Pennsylvania | Method for removing skin wrinkles |
US5095915A (en) * | 1990-03-19 | 1992-03-17 | Target Therapeutics | Guidewire with flexible distal tip |
US5109830A (en) * | 1990-04-10 | 1992-05-05 | Candela Laser Corporation | Apparatus for navigation of body cavities |
US5197978A (en) * | 1991-04-26 | 1993-03-30 | Advanced Coronary Technology, Inc. | Removable heat-recoverable tissue supporting device |
US5197978B1 (en) * | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
US5276455A (en) * | 1991-05-24 | 1994-01-04 | The Boeing Company | Packaging architecture for phased arrays |
US5213111A (en) * | 1991-07-10 | 1993-05-25 | Cook Incorporated | Composite wire guide construction |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5725570A (en) * | 1992-03-31 | 1998-03-10 | Boston Scientific Corporation | Tubular medical endoprostheses |
US5498236A (en) * | 1992-05-19 | 1996-03-12 | Dubrul; Will R. | Vibrating catheter |
US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5397293A (en) * | 1992-11-25 | 1995-03-14 | Misonix, Inc. | Ultrasonic device with sheath and transverse motion damping |
US6527802B1 (en) * | 1993-01-19 | 2003-03-04 | Scimed Life Systems, Inc. | Clad composite stent |
US5628787A (en) * | 1993-01-19 | 1997-05-13 | Schneider (Usa) Inc. | Clad composite stent |
US5496330A (en) * | 1993-02-19 | 1996-03-05 | Boston Scientific Corporation | Surgical extractor with closely angularly spaced individual filaments |
US5489227A (en) * | 1993-09-03 | 1996-02-06 | Sanshin Kogyo Kabushiki Kaisha | Protective cowling for outboard motor |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5891193A (en) * | 1993-11-04 | 1999-04-06 | C.R. Bard, Inc. | Non-migrating vascular prosthesis and minimally invasive placement system therefor |
US5725549A (en) * | 1994-03-11 | 1998-03-10 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US6017362A (en) * | 1994-04-01 | 2000-01-25 | Gore Enterprise Holdings, Inc. | Folding self-expandable intravascular stent |
US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US6033719A (en) * | 1996-04-25 | 2000-03-07 | Medtronic, Inc. | Method for covalent attachment of biomolecules to surfaces of medical devices |
US5891191A (en) * | 1996-04-30 | 1999-04-06 | Schneider (Usa) Inc | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
US6027528A (en) * | 1996-05-28 | 2000-02-22 | Cordis Corporation | Composite material endoprosthesis |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US6015432A (en) * | 1998-02-25 | 2000-01-18 | Cordis Corporation | Wire reinforced vascular prosthesis |
US6206915B1 (en) * | 1998-09-29 | 2001-03-27 | Medtronic Ave, Inc. | Drug storing and metering stent |
Also Published As
Publication number | Publication date |
---|---|
US20100070025A1 (en) | 2010-03-18 |
US7101392B2 (en) | 2006-09-05 |
US20020035396A1 (en) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7101392B2 (en) | Tubular medical endoprostheses | |
US6287331B1 (en) | Tubular medical prosthesis | |
US6248190B1 (en) | Process of making composite stents with gold alloy cores | |
US6887265B2 (en) | Balloon expandable covered stents | |
EP0947204B1 (en) | Composite material endoprosthesis | |
JP4652375B2 (en) | Endoprosthesis | |
US6527802B1 (en) | Clad composite stent | |
US5628787A (en) | Clad composite stent | |
US20090276033A1 (en) | Clad Composite Stent | |
US8435280B2 (en) | Flexible stent with variable width elements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC TECHNOLOGY, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC CORPORATION;REEL/FRAME:018515/0585 Effective date: 19950701 Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC TECHNOLOGY, INC.;REEL/FRAME:018480/0075 Effective date: 19971215 Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018480/0107 Effective date: 20050101 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |